Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models

Digestive Diseases and Sciences

Volumn 55, Issue 6, 2010, Pages 1589-1598

  Shalev, Tamar ^a   Aeed, Hussein ^a   Sorin, Vladimir ^a   Shahmurov, Mark ^a   Didkovsky, Elena ^a   Ilan, Yaron ^b   Avni, Yona ^a   Shirin, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Breath test; Liver; Octanoate

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; OCTANOIC ACID C 13; THIOACETAMIDE; 4 ACETANISIDINE; ACETAMIDE DERIVATIVE; CARBON; CARBON DIOXIDE; DIAGNOSTIC AGENT; OCTANOIC ACID; OCTANOIC ACID DERIVATIVE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; BREATH ANALYSIS; CONTROLLED STUDY; HEPATITIS; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; COMMON BILE DUCT; DISEASE MODEL; EVALUATION; EXPERIMENTAL LIVER CIRRHOSIS; LIGATION; LIVER; MALE; METABOLISM; OBSTRUCTIVE JAUNDICE; PATHOLOGY; PREDICTION AND FORECASTING; TIME; TOXIC HEPATITIS; WISTAR RAT;

ACETAMIDES; ACUTE DISEASE; ANIMALS; BREATH TESTS; CARBON DIOXIDE; CARBON ISOTOPES; CHOLESTASIS, EXTRAHEPATIC; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; LIGATION; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; OCTANOIC ACIDS; PREDICTIVE VALUE OF TESTS; RATS; RATS, WISTAR; THIOACETAMIDE; TIME FACTORS;

EID: 77954422123     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0913-2     Document Type: Article

References (32)

1. A Armuzzi M Candelli MA Zocco A Andreoli A De Lorenzo EC Nista L Miele F Cremonini IA Cazzato A Grieco G Gasbarrini A Gasbarrini 2002 Review article: breath testing for human liver function assessment Aliment Pharmacol Ther 16 1977 1996 10.1046/j.1365-2036.2002.01374.x 1:STN:280:DC%2BD38nptFylsg%3D%3D 12452932 (Pubitemid 36009162)
2. S Krahenbuhl 1993 Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention Pharmacol Ther 60 1 38 10.1016/0163-7258(93)90020-E 1:STN:280: DyaK2c7ntl2mtw%3D%3D 8127921 (Pubitemid 24052880)
3. B Fromenty D Pessayre 1995 Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity Pharmacol Ther 67 101 154 10.1016/0163-7258(95) 00012-6 1:CAS:528:DyaK2MXnvVKrs78%3D 7494860
4. G Barbaro G Di Lorenzo A Asti M Ribersani G Belloni B Grisorio G Filice G Barbarini 1999 Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings Am J Gastroenterol 94 2198 2205 10.1111/j.1572-0241.1999.01294.x 1:STN:280:DyaK1Mznt1OhsA%3D%3D 10445550 (Pubitemid 29374554)
5. B Fromenty D Pessayre 1997 Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines J Hepatol 26 Suppl 2 43 53 10.1016/S0168-8278(97)80496-5 1:CAS:528: DyaK2sXkt1Ont7k%3D 9204409 (Pubitemid 27229589)
6. AJ Sanyal C Campbell-Sargent F Mirshahi WB Rizzo MJ Contos RK Sterling VA Luketic ML Shiffman JN Clore 2001 Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 1183 1192 10.1053/gast.2001.23256 1:CAS:528:DC%2BD3MXjtVeqsb8%3D 11266382 (Pubitemid 32246672)
7. B Fromenty MA Robin A Igoudjil A Mansouri D Pessayre 2004 The ins and outs of mitochondrial dysfunction in NASH Diabet Metab 30 121 138 10.1016/S1262-3636(07)70098-8 1:CAS:528:DC%2BD2cXltlKht7Y%3D (Pubitemid 38715168)
8. S Krahenbuhl S Krahenbuhl-Glauser J Stucki P Gehr J Reichen 1992 Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte Hepatology 15 1167 1172 10.1002/hep.1840150631 1:STN:280:DyaK383nsFGmtw%3D%3D 1592355
9. L Krahenbuhl M Ledermann C Lang S Krahenbuhl 2000 Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced cirrhosis J Hepatol 33 216 223 10.1016/S0168-8278(00) 80362-1 1:CAS:528:DC%2BD3cXlvVylurc%3D 10952239 (Pubitemid 30485225)
10. YF Ghoos BD Maes BJ Geypens G Mys MI Hiele PJ Rutgeerts G Vantrappen 1993 Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoc acid breath test Gastroenterology 104 1640 1647 1:STN:280: DyaK3s3ntlWkuw%3D%3D 8500721 (Pubitemid 23235453)
11. BD Maes G Mys BJ Geypens P Evenepoel YF Ghoos PJ Rutgeerts 1998 Gastric emptying flow curves separated from carbon-labeled octanoic acid breath tests results Am J Physiol 275 G169 G175 1:CAS:528:DyaK1cXkvVOnu7o%3D 9655697 (Pubitemid 28374686)
12. E Guillot P Vaugelade P Lemarchal A Rerat 1993 Intestinal absorption and liver uptake of medium-chain fatty acids in non-anaesthetized pigs Br J Nutr 69 431 442 10.1079/BJN19930045 1:CAS:528:DyaK3sXisFeqsrk%3D 8489999 (Pubitemid 23105481)
13. A Papamandrjaris D Mac Dougall P Jones 1998 Medium-chain fatty acid metabolism and energy expenditure: obesity treatment implications Life Sci 62 1203 1215 10.1016/S0024-3205(97)01143-0 (Pubitemid 28153503)
14. 13C-octanoate breath test AJG 98 2335 2336 10.1111/j.1572-0241.2003.07725.x (Pubitemid 37305387)
15. 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men Eur J Gastroenterol Hepatol 17 1181 1184 10.1097/00042737-200511000-00005 1:CAS:528:DC%2BD2MXhtVymtL7N 16215429 (Pubitemid 41527434)
16. M Braun O Pappo E Zuckerman Y Kitai M Moreno O Cohen H Schmilovitz-Weiss Y Rotman D Zamir S Melnik R Tur Kaspa Z Ben Ari 2005 The unique BreathID test system diagnoses and predicts the extent of hepatic injury in patients with nonalcoholic fatty liver disease Hepatology 42 752A 10.1016/j.jhep.2004.12.032 (Pubitemid 40501693)
17. M Van De Casteele A Luypaerts B Geypens J Fevery Y Ghoos F Nevens 2003 Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease Neurogastroenterol Motil 15 113 120 10.1046/j.1365-2982.2003.00397.x 12680910 (Pubitemid 36532549)
18. C Zimmermann P Ferenci C Pifl C Yurdaydin J Ebner H Lassmann E Roth H Hortnaql 1989 Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission Hepatology 9 595 601 10.1002/hep.1840090414 (Pubitemid 19094584)
19. N Hori T Okanoue Y Sawa T Mori K Kashima 1993 Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration Dig Dis Sci 38 2195 2202 10.1007/BF01299895 1:CAS:528: DyaK2cXktVaktL8%3D 8261820 (Pubitemid 24035751)
20. J Kountouras BH Billing PJ Scheuer 1984 Prolonged bile duct ligation obstruction: a new experimental model of cirrhosis in the rat Br J Exp Pathol 65 305 311 1:STN:280:DyaL2c3lslChsg%3D%3D 6743531 (Pubitemid 14085298)
21. H Zimmermann H Blaser A Zimmermann J Reichen 1994 Effect of development on the functional and histological changes induced by bile-duct ligation on the rat J Hepatology 20 231 239 10.1016/S0168-8278(05)80063-7 1:CAS:528: DyaK2cXjtFGisLk%3D (Pubitemid 24086838)
22. JF Woessner 1961 The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid Arch Biochem Biophys 93 440 447 10.1016/0003-9861(61)90291-0 1:CAS:528:DyaF3MXht1Ghu7c%3D 13786180
23. KP Batts J Ludwig 1995 Chronic hepatitis. An update on terminology and reporting Am J Sur Pathol 19 1409 1417 10.1097/00000478-199512000-00007 1:STN:280:DyaK28%2FotlKkug%3D%3D
24. KS Lee M Buck K Houglum M Chojkier 1995 Activation of hepatic stellate cells by TGF alpha and collagen type 1 is mediated by oxidative stress through c-myb expression J Clin Invest 96 2461 2468 10.1172/JCI118304 1:CAS:528:DyaK28XltF2gtg%3D%3D 7593635
25. R Bruck H Shirin H Aeed Z Matas A Hochman M Pines Y Avni 2001 Prevention of hepatic cirrhosis by hydroxyl radical scavengers J Hepatology 35 457 464 10.1016/S0168-8278(01)00163-5 1:CAS:528:DC%2BD3MXot1Sms70%3D (Pubitemid 32964444)
26. D Muller M Sommer M Kretzschmar T Zimmermann V Buko OJ Lukivskaya L Dargel 1991 Lipid peroxidation in thioacetamide-induced macronodular rat liver cirrhosis Arch Toxycol 65 199 203 10.1007/BF02307309 1:STN:280: DyaK3M3ntlGgsA%3D%3D
27. A Muller A Machnik T Zimmermann H Schubert 1988 Thioacetamide induced cirrhosis-like lesions in rats-usefulness and reliability of this animal model Exp Pathol 34 229 236 1:STN:280:DyaL1M7ntFWgug%3D%3D 2853079
28. N Yamamura Y Magata J Konishi H Saji 1999 Evaluation of radioiodinated medium chain fatty acids as new diagnostic agents for the determinants of hepatic viability Eur J Nucl Med 26 1597 1605 10.1007/s002590050500 1:CAS:528:DyaK1MXnsl2rsb0%3D 10638412 (Pubitemid 30010298)
29. 13C-NMR spectroscopy in rat skeletal muscle, heart and liver J Appl Physiol 95 1908 1916 1:CAS:528:DC%2BD3sXptlWrtbw%3D 12882988 (Pubitemid 37310375)
30. L Krahenbuhl M Schafer S Krahenbuhl 1998 Reversibility of hepatic mitochondrial damage in rats with long-term cholestasis J Hepatol 28 1000 1007 10.1016/S0168-8278(98)80349-8 1:CAS:528:DyaK1cXmvVSltb0%3D 9672176 (Pubitemid 28275979)
31. 13C-Methacetin breath test in evaluating hepatic injury in rats J Gastro Hepatol 23 1762 1768 10.1111/j.1440-1746.2008.05431.x
32. 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis Scand J Gastroenterol 41 1336 1341 10.1080/00365520600670125 1:CAS:528:DC%2BD28XhtlanurzJ 17060128 (Pubitemid 44639307)